Buying Buzz: Aytu BioPharma Inc [AYTU] Chief Business Officer Disbrow Jarrett acquires 16,666 shares of the company

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Aytu BioPharma Inc shares valued at $24,999 were purchased by Disbrow Jarrett on Jun 09 ’25. At $1.50 per share, Disbrow Jarrett acquired 16,666 shares. The insider’s holdings grew to 29,462 shares worth approximately $58040.14 following the completion of this transaction.

Also, Disbrow Joshua R. purchased 66,666 shares, netting a total of over 99,999 in proceeds. Following the buying of shares at $1.50 each, the insider now holds 153,257 shares.

Before that, Disbrow Joshua R. had added 15,000 shares to its account. In a trade valued at $19,500, the Chief Executive Officer bought Aytu BioPharma Inc shares for $1.30 each. Upon closing the transaction, the insider’s holdings increased to 15,000 shares, worth approximately $0.17 million.

As published in their initiating research note from Cantor Fitzgerald on March 30, 2021, Aytu BioPharma Inc [AYTU] has been an Overweight and the price target has been revised to $11. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in late May.

Analyzing AYTU Stock Performance

The stock’s lowest price that day was $1.93, but it reached a high of $2.0468 in the same session. During the last five days, there has been a surge of approximately 2.07%. Over the course of the year, Aytu BioPharma Inc shares have jumped approximately 15.88%. Shares of the company reached a 52-week high of $2.7000 on 05/15/25 and a 52-week low of $0.9500 on 04/07/25.

Support And Resistance Levels for Aytu BioPharma Inc (AYTU)

According to the 24-hour chart, there is a support level at 1.9177, which, if violated, would cause prices to drop to 1.8655. In the upper region, resistance lies at 2.0345. The next price resistance is at 2.0991. RSI (Relative Strength Index) is 57.45 on the 14-day chart, showing neutral technical sentiment.

Is Aytu BioPharma Inc subject to short interest?

Stocks of Aytu BioPharma Inc saw a sharp rise in short interest on 2025-05-30 jumping by 0.28 million shares to 0.42 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 0.14 million shares. A jump of 67.42% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 0.12 of the overall float, the days-to-cover ratio (short ratio) jumped to 0.12.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.